nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G7—blood plasma—bipolar disorder	0.0466	0.112	CbGeAlD
Orlistat—PNLIP—blood plasma—bipolar disorder	0.041	0.0983	CbGeAlD
Orlistat—ABHD16A—adrenal cortex—bipolar disorder	0.0222	0.0533	CbGeAlD
Orlistat—DAGLA—nervous system—bipolar disorder	0.0221	0.0531	CbGeAlD
Orlistat—DAGLA—cerebellum—bipolar disorder	0.0208	0.05	CbGeAlD
Orlistat—ABHD12—adrenal cortex—bipolar disorder	0.0208	0.0499	CbGeAlD
Orlistat—DAGLB—thyroid gland—bipolar disorder	0.0204	0.049	CbGeAlD
Orlistat—DAGLA—brain—bipolar disorder	0.0169	0.0406	CbGeAlD
Orlistat—PLA2G4A—blood plasma—bipolar disorder	0.0165	0.0397	CbGeAlD
Orlistat—PLA2G7—thyroid gland—bipolar disorder	0.0165	0.0395	CbGeAlD
Orlistat—DAGLB—cerebellum—bipolar disorder	0.0161	0.0387	CbGeAlD
Orlistat—ABHD16A—thyroid gland—bipolar disorder	0.0155	0.0371	CbGeAlD
Orlistat—ABHD12—thyroid gland—bipolar disorder	0.0145	0.0348	CbGeAlD
Orlistat—DAGLB—brain—bipolar disorder	0.0131	0.0315	CbGeAlD
Orlistat—ABHD16A—cerebellum—bipolar disorder	0.0122	0.0294	CbGeAlD
Orlistat—FASN—thyroid gland—bipolar disorder	0.0122	0.0292	CbGeAlD
Orlistat—ABHD12—cerebellum—bipolar disorder	0.0115	0.0275	CbGeAlD
Orlistat—PLA2G7—brain—bipolar disorder	0.0106	0.0254	CbGeAlD
Orlistat—CYP3A4—urine—bipolar disorder	0.0104	0.0251	CbGeAlD
Orlistat—FASN—cerebellum—bipolar disorder	0.00962	0.0231	CbGeAlD
Orlistat—ABHD12—brain—bipolar disorder	0.00931	0.0224	CbGeAlD
Orlistat—PLA2G4A—adrenal cortex—bipolar disorder	0.00839	0.0201	CbGeAlD
Orlistat—FASN—brain—bipolar disorder	0.00781	0.0188	CbGeAlD
Orlistat—PLA2G4A—thyroid gland—bipolar disorder	0.00584	0.014	CbGeAlD
Orlistat—CYP3A4—blood plasma—bipolar disorder	0.00545	0.0131	CbGeAlD
Orlistat—PLA2G4A—nervous system—bipolar disorder	0.00491	0.0118	CbGeAlD
Orlistat—PLA2G4A—brain—bipolar disorder	0.00376	0.00902	CbGeAlD
Orlistat—CYP3A4—nervous system—bipolar disorder	0.00162	0.00389	CbGeAlD
Orlistat—DAGLA—GPCR downstream signaling—DRD2—bipolar disorder	0.000779	0.00134	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DGKH—bipolar disorder	0.000768	0.00132	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—DRD4—bipolar disorder	0.00076	0.0013	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—DRD4—bipolar disorder	0.00076	0.0013	CbGpPWpGaD
Orlistat—PLA2G4A—Opioid Signalling—POMC—bipolar disorder	0.000752	0.00129	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.000745	0.00128	CbGpPWpGaD
Orlistat—FASN—Metabolism—NDUFV2—bipolar disorder	0.000729	0.00125	CbGpPWpGaD
Orlistat—FASN—Disease—NCAN—bipolar disorder	0.000724	0.00124	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—POMC—bipolar disorder	0.000716	0.00123	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—ADCY2—bipolar disorder	0.000715	0.00123	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—ADCY2—bipolar disorder	0.000715	0.00123	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—INS—bipolar disorder	0.000712	0.00122	CbGpPWpGaD
Orlistat—FASN—Disease—SLC5A3—bipolar disorder	0.00071	0.00122	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—DRD2—bipolar disorder	0.000708	0.00121	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—DRD2—bipolar disorder	0.000708	0.00121	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKR1C4—bipolar disorder	0.000706	0.00121	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD5—bipolar disorder	0.000702	0.0012	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RGS4—bipolar disorder	0.000689	0.00118	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—DGKH—bipolar disorder	0.000688	0.00118	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00068	0.00117	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TRPC3—bipolar disorder	0.000642	0.0011	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TRPC3—bipolar disorder	0.000642	0.0011	CbGpPWpGaD
Orlistat—FASN—Metabolism—NR1D1—bipolar disorder	0.000634	0.00109	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ADM—bipolar disorder	0.000613	0.00105	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ADM—bipolar disorder	0.000613	0.00105	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000612	0.00105	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000611	0.00105	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CLOCK—bipolar disorder	0.000607	0.00104	CbGpPWpGaD
Orlistat—FASN—Metabolism—NCAN—bipolar disorder	0.000607	0.00104	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PDE4B—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TSHB—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TACR1—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TSHB—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PDE4B—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TACR1—bipolar disorder	0.000597	0.00102	CbGpPWpGaD
Orlistat—FASN—Metabolism—SLC5A3—bipolar disorder	0.000594	0.00102	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—TSHB—bipolar disorder	0.000592	0.00101	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—TPH2—bipolar disorder	0.000592	0.00101	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CACNB2—bipolar disorder	0.000592	0.00101	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—DPYD—bipolar disorder	0.000582	0.000998	CbGpPWpGaD
Orlistat—PNLIP—Disease—SNAP25—bipolar disorder	0.000565	0.000968	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000561	0.000961	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR2A—bipolar disorder	0.000546	0.000936	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR2A—bipolar disorder	0.000546	0.000936	CbGpPWpGaD
Orlistat—PNLIP—Disease—GSK3A—bipolar disorder	0.000545	0.000934	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—IMPA2—bipolar disorder	0.000545	0.000934	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CACNA1C—bipolar disorder	0.000541	0.000928	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TRPC3—bipolar disorder	0.000532	0.000912	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3C2A—bipolar disorder	0.000527	0.000904	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.00052	0.000892	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADM—bipolar disorder	0.000508	0.00087	CbGpPWpGaD
Orlistat—PNLIP—Disease—ADCY2—bipolar disorder	0.0005	0.000857	CbGpPWpGaD
Orlistat—PNLIP—Disease—TCF7L2—bipolar disorder	0.000498	0.000854	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR2A—bipolar disorder	0.000496	0.00085	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR2A—bipolar disorder	0.000496	0.00085	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TSHB—bipolar disorder	0.000495	0.000848	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PDE4B—bipolar disorder	0.000495	0.000848	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TACR1—bipolar disorder	0.000495	0.000848	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR1A—bipolar disorder	0.000494	0.000847	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR1A—bipolar disorder	0.000494	0.000847	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TAC1—bipolar disorder	0.000487	0.000834	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TAC1—bipolar disorder	0.000487	0.000834	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD1—bipolar disorder	0.000477	0.000818	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD1—bipolar disorder	0.000477	0.000818	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2C—bipolar disorder	0.000477	0.000818	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2C—bipolar disorder	0.000477	0.000818	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TRPC3—bipolar disorder	0.000477	0.000817	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—SNAP25—bipolar disorder	0.000473	0.000811	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NTRK2—bipolar disorder	0.000464	0.000796	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NTRK2—bipolar disorder	0.000464	0.000796	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD3—bipolar disorder	0.000462	0.000792	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD3—bipolar disorder	0.000462	0.000792	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GSK3A—bipolar disorder	0.00046	0.000789	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GSK3A—bipolar disorder	0.00046	0.000789	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD4—bipolar disorder	0.000449	0.000769	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD4—bipolar disorder	0.000449	0.000769	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—POMC—bipolar disorder	0.000436	0.000747	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—POMC—bipolar disorder	0.000436	0.000747	CbGpPWpGaD
Orlistat—FASN—Metabolism—CLOCK—bipolar disorder	0.00043	0.000736	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ADCY2—bipolar disorder	0.000422	0.000724	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ADCY2—bipolar disorder	0.000422	0.000724	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TCF7L2—bipolar disorder	0.000421	0.000722	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TCF7L2—bipolar disorder	0.000421	0.000722	CbGpPWpGaD
Orlistat—FASN—Metabolism—TSHB—bipolar disorder	0.000419	0.000718	CbGpPWpGaD
Orlistat—FASN—Metabolism—TPH2—bipolar disorder	0.000419	0.000718	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ADCY2—bipolar disorder	0.000419	0.000718	CbGpPWpGaD
Orlistat—FASN—Metabolism—CACNB2—bipolar disorder	0.000419	0.000718	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD2—bipolar disorder	0.000418	0.000717	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD2—bipolar disorder	0.000418	0.000717	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINA1—bipolar disorder	0.000417	0.000714	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000414	0.00071	CbGpPWpGaD
Orlistat—FASN—Metabolism—DPYD—bipolar disorder	0.000412	0.000706	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR1A—bipolar disorder	0.00041	0.000702	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000409	0.000701	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TAC1—bipolar disorder	0.000403	0.000691	CbGpPWpGaD
Orlistat—FASN—Disease—SNAP25—bipolar disorder	0.0004	0.000685	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—POMC—bipolar disorder	0.000396	0.000679	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—POMC—bipolar disorder	0.000396	0.000679	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2C—bipolar disorder	0.000396	0.000678	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD1—bipolar disorder	0.000396	0.000678	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DGKH—bipolar disorder	0.000395	0.000676	CbGpPWpGaD
Orlistat—FASN—Disease—GSK3A—bipolar disorder	0.000385	0.000661	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NTRK2—bipolar disorder	0.000385	0.00066	CbGpPWpGaD
Orlistat—PNLIP—Disease—NRG1—bipolar disorder	0.000384	0.000659	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD3—bipolar disorder	0.000383	0.000657	CbGpPWpGaD
Orlistat—FASN—Metabolism—CACNA1C—bipolar disorder	0.000383	0.000656	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GSK3A—bipolar disorder	0.000381	0.000654	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NTRK1—bipolar disorder	0.000379	0.000649	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NTRK1—bipolar disorder	0.000379	0.000649	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3C2A—bipolar disorder	0.000373	0.00064	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD4—bipolar disorder	0.000372	0.000637	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000368	0.000631	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—S100B—bipolar disorder	0.000368	0.000631	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—S100B—bipolar disorder	0.000368	0.000631	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—IMPA1—bipolar disorder	0.000368	0.000631	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD5—bipolar disorder	0.000361	0.000619	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00036	0.000616	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—COMT—bipolar disorder	0.000359	0.000615	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MAOA—bipolar disorder	0.000356	0.00061	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—GATA3—bipolar disorder	0.000354	0.000607	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—RGS4—bipolar disorder	0.000354	0.000607	CbGpPWpGaD
Orlistat—FASN—Disease—ADCY2—bipolar disorder	0.000354	0.000606	CbGpPWpGaD
Orlistat—FASN—Disease—TCF7L2—bipolar disorder	0.000352	0.000604	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADCY2—bipolar disorder	0.00035	0.0006	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TCF7L2—bipolar disorder	0.000349	0.000598	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD2—bipolar disorder	0.000346	0.000594	CbGpPWpGaD
Orlistat—PNLIP—Disease—MTHFR—bipolar disorder	0.000346	0.000593	CbGpPWpGaD
Orlistat—FASN—Metabolism—SNAP25—bipolar disorder	0.000335	0.000574	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NRG1—bipolar disorder	0.000325	0.000557	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NRG1—bipolar disorder	0.000325	0.000557	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NTRK1—bipolar disorder	0.000314	0.000538	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NDUFV2—bipolar disorder	0.000313	0.000536	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—S100B—bipolar disorder	0.000305	0.000523	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKR1C4—bipolar disorder	0.000303	0.000519	CbGpPWpGaD
Orlistat—FASN—Metabolism—ADCY2—bipolar disorder	0.000296	0.000508	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2A—bipolar disorder	0.000293	0.000502	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2A—bipolar disorder	0.000293	0.000502	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MTHFR—bipolar disorder	0.00029	0.000497	CbGpPWpGaD
Orlistat—PNLIP—Disease—GSK3B—bipolar disorder	0.000279	0.000478	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000279	0.000478	CbGpPWpGaD
Orlistat—PNLIP—Disease—INS—bipolar disorder	0.000275	0.000472	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TRPC3—bipolar disorder	0.000274	0.000469	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NR1D1—bipolar disorder	0.000272	0.000466	CbGpPWpGaD
Orlistat—FASN—Disease—NRG1—bipolar disorder	0.000272	0.000466	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NRG1—bipolar disorder	0.000269	0.000461	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADM—bipolar disorder	0.000261	0.000447	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NCAN—bipolar disorder	0.00026	0.000446	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC5A3—bipolar disorder	0.000255	0.000437	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TSHB—bipolar disorder	0.000254	0.000436	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PDE4B—bipolar disorder	0.000254	0.000436	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TACR1—bipolar disorder	0.000254	0.000436	CbGpPWpGaD
Orlistat—FASN—Metabolism—COMT—bipolar disorder	0.000254	0.000435	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKR1C4—bipolar disorder	0.000253	0.000434	CbGpPWpGaD
Orlistat—FASN—Metabolism—MAOA—bipolar disorder	0.000252	0.000432	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—bipolar disorder	0.000245	0.00042	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—bipolar disorder	0.000243	0.000416	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GSK3B—bipolar disorder	0.000236	0.000404	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GSK3B—bipolar disorder	0.000236	0.000404	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—POMC—bipolar disorder	0.000234	0.000401	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—POMC—bipolar disorder	0.000234	0.000401	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DGKH—bipolar disorder	0.000233	0.0004	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—INS—bipolar disorder	0.000233	0.000399	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—INS—bipolar disorder	0.000233	0.000399	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—POMC—bipolar disorder	0.000232	0.000397	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—INS—bipolar disorder	0.00023	0.000395	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000224	0.000384	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD5—bipolar disorder	0.000213	0.000365	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1A—bipolar disorder	0.000211	0.000361	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RGS4—bipolar disorder	0.000209	0.000358	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TAC1—bipolar disorder	0.000207	0.000355	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—bipolar disorder	0.000205	0.000351	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2C—bipolar disorder	0.000203	0.000348	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD1—bipolar disorder	0.000203	0.000348	CbGpPWpGaD
Orlistat—FASN—Disease—GSK3B—bipolar disorder	0.000197	0.000338	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD3—bipolar disorder	0.000197	0.000337	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GSK3B—bipolar disorder	0.000195	0.000335	CbGpPWpGaD
Orlistat—FASN—Disease—INS—bipolar disorder	0.000195	0.000334	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—POMC—bipolar disorder	0.000194	0.000332	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—INS—bipolar disorder	0.000193	0.00033	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD4—bipolar disorder	0.000191	0.000328	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CLOCK—bipolar disorder	0.000184	0.000316	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000181	0.000311	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADCY2—bipolar disorder	0.00018	0.000308	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TSHB—bipolar disorder	0.00018	0.000308	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNB2—bipolar disorder	0.00018	0.000308	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TPH2—bipolar disorder	0.00018	0.000308	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD2—bipolar disorder	0.000178	0.000305	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DPYD—bipolar disorder	0.000177	0.000303	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNA1C—bipolar disorder	0.000164	0.000282	CbGpPWpGaD
Orlistat—FASN—Metabolism—POMC—bipolar disorder	0.000164	0.000281	CbGpPWpGaD
Orlistat—FASN—Metabolism—INS—bipolar disorder	0.000163	0.00028	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TRPC3—bipolar disorder	0.000162	0.000277	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3C2A—bipolar disorder	0.00016	0.000274	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000158	0.000271	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADM—bipolar disorder	0.000154	0.000264	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDE4B—bipolar disorder	0.00015	0.000258	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TSHB—bipolar disorder	0.00015	0.000258	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TACR1—bipolar disorder	0.00015	0.000258	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000149	0.000256	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000148	0.000254	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000147	0.000252	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SNAP25—bipolar disorder	0.000144	0.000246	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000128	0.000219	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADCY2—bipolar disorder	0.000127	0.000218	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—bipolar disorder	0.000125	0.000214	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1A—bipolar disorder	0.000124	0.000213	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TAC1—bipolar disorder	0.000122	0.00021	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2C—bipolar disorder	0.00012	0.000206	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD1—bipolar disorder	0.00012	0.000206	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK2—bipolar disorder	0.000117	0.0002	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD3—bipolar disorder	0.000116	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3A—bipolar disorder	0.000116	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD4—bipolar disorder	0.000113	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—COMT—bipolar disorder	0.000109	0.000187	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOA—bipolar disorder	0.000108	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADCY2—bipolar disorder	0.000106	0.000182	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TCF7L2—bipolar disorder	0.000106	0.000182	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD2—bipolar disorder	0.000105	0.00018	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—POMC—bipolar disorder	9.96e-05	0.000171	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—POMC—bipolar disorder	9.64e-05	0.000165	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK1—bipolar disorder	9.52e-05	0.000163	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—S100B—bipolar disorder	9.26e-05	0.000159	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—bipolar disorder	8.8e-05	0.000151	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—IMPA1—bipolar disorder	8.62e-05	0.000148	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NRG1—bipolar disorder	8.17e-05	0.00014	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—bipolar disorder	7.37e-05	0.000126	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDUFV2—bipolar disorder	7.33e-05	0.000126	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKR1C4—bipolar disorder	7.09e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—POMC—bipolar disorder	7.04e-05	0.000121	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—INS—bipolar disorder	7e-05	0.00012	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NR1D1—bipolar disorder	6.37e-05	0.000109	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NCAN—bipolar disorder	6.1e-05	0.000104	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC5A3—bipolar disorder	5.97e-05	0.000102	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3B—bipolar disorder	5.93e-05	0.000102	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—POMC—bipolar disorder	5.88e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—INS—bipolar disorder	5.85e-05	0.0001	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CLOCK—bipolar disorder	4.32e-05	7.4e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TSHB—bipolar disorder	4.21e-05	7.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TPH2—bipolar disorder	4.21e-05	7.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNB2—bipolar disorder	4.21e-05	7.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DPYD—bipolar disorder	4.14e-05	7.1e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNA1C—bipolar disorder	3.85e-05	6.6e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.75e-05	6.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SNAP25—bipolar disorder	3.36e-05	5.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADCY2—bipolar disorder	2.98e-05	5.1e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—COMT—bipolar disorder	2.55e-05	4.37e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOA—bipolar disorder	2.53e-05	4.34e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.06e-05	3.53e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—POMC—bipolar disorder	1.65e-05	2.82e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—INS—bipolar disorder	1.64e-05	2.81e-05	CbGpPWpGaD
